An educational event was hosted by laser developer and manufacturer Cynosure UK on March 21 as part of its Aesthetic Exchange learning and development programme.
Hosted by dermatologist Dr Christine Dierickx at Chandos House, London, the educational dinner and discussion was attended by practitioners from clinics across the UK and focused on the latest research on picosecond technology for the management of pigmentation and melasma.
Dr Dierickx showcased how and why she uses the PicoSure 755 nm laser when dealing with the management of pigmentation, melasma and a variety of other dermatological conditions.
Donna Freeman, clinical research manager at Cynosure Europe, Middle East and Africa, explored the current data and clinical evidence as well as future progress of picosecond research for non-tattoo applications, including management of scarring, benign cutaneous pigmented lesions and melasma. She also explored comparative studies with a focus on the safety and efficacy of the technology and why wavelength choice is so critical for clinical success.
Cynosure UK and Ireland sales director Ben Savigar-Jones was also in attendance to assist practitioners with any additional questions they had about the PicoSure device.
Following the event Dr Dierickx said, “Picosecond technology is fast becoming the dermatologist tool of choice for treating challenging pigmentation conditions. This session helped outline the kinds of results that can be achieved with PicoSure and provided a useful educational forum for delegates to share their own experiences and key learnings for best practice and optimum patient outcomes.”
According to Cynosure, key learnings from the session will be made available via the exclusive Aesthetic Exchange learning platform for customers.